Anorexia, weight loss and cachexia are the most visibly recognizable symptoms associated with cancer. However, the causes of cancer cachexia remain unknown. This application proposes that the anorexia, losses of lean tissue and body fat, and the hepatic acute phase response in patients or experimental animals with cancer can be attributed in part to an inappropriate or excessive production of cytokines, including interleukin-1 alpha or beta (IL-1), tumor necrosis factor-alpha (TNF-alpha/cachectin) and/or interleukin-6 (interferon-beta2). Experimental evidence suggests that either the tumor itself or tumor-infiltrating macrophages and other accessory cells, blood monocytes, or macrophages contained in organs of the reticuloendothelial system may be spontaneously releasing one or more of these cytokines. Therefore, in this application, cytokine production (IL- 1. TNF-alpha and IL-6) will be evaluated directly in the tumors of cachectic mice and of weight-losing patients by measuring both the quantity of cytokine-specific mRNA and immune reactive protein present, and from organs of the reticuloendothelial system of tumor-bearing mice. In addition, to determine whether the production of one or more of these cytokines is contributing directly to the development of cancer cachexia, specific neutralizing polyclonal and monoclonal antibodies directed against these cytokines and/or their tissue receptors will be administered in vivo to tumor-bearing mice in order to determine whether blocking the actions of these cytokines can either reduce the severity of or prevent the development of cancer cachexia. Thus, the specific goal of this application is to determine whether tumor specific or associated cytokine production are common findings in experimental and human cancer, whether the cytokines are of tumor or host origin, and finally, whether the host changes in food intake, carcass protein and fat composition, and hepatic acute phase response can be attributed to the inappropriate production of these cytokines.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA052108-03
Application #
3196888
Study Section
Metabolic Pathology Study Section (MEP)
Project Start
1990-07-01
Project End
1995-04-30
Budget Start
1992-06-01
Budget End
1993-04-30
Support Year
3
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Espat, N J; Auffenberg, T; Abouhamze, A et al. (1996) A role for tumor necrosis factor-alpha in the increased mortality associated with Vibrio vulnificus infection in the presence of hepatic dysfunction. Ann Surg 223:428-33
Calvano, S E; van der Poll, T; Coyle, S M et al. (1996) Monocyte tumor necrosis factor receptor levels as a predictor of risk in human sepsis. Arch Surg 131:434-7
Pruitt, J H; Welborn, M B; Edwards, P D et al. (1996) Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood 87:3282-8
Espat, N J; Auffenberg, T; Rosenberg, J J et al. (1996) Ciliary neurotrophic factor is catabolic and shares with IL-6 the capacity to induce an acute phase response. Am J Physiol 271:R185-90
Rogy, M A; Oldenburg, H S; Coyle, S et al. (1996) Correlation between Acute Physiology and Chronic Health Evaluation (APACHE) III score and immunological parameters in critically ill patients with sepsis. Br J Surg 83:396-400
Jansen, P M; Boermeester, M A; Fischer, E et al. (1995) Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory-type phospholipase A2 in sepsis: studies in nonhuman primates after interleukin-1 alpha administration and during lethal ba Blood 86:1027-34
Van Zee, K J; Coyle, S M; Calvano, S E et al. (1995) Influence of IL-1 receptor blockade on the human response to endotoxemia. J Immunol 154:1499-507
Espat, N J; Moldawer, L L; Copeland 3rd, E M (1995) Cytokine-mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer patients. J Surg Oncol 58:77-82
van der Poll, T; Van Zee, K J; Endert, E et al. (1995) Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in man. J Clin Endocrinol Metab 80:1341-6
Rogy, M A; Auffenberg, T; Espat, N J et al. (1995) Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses. J Exp Med 181:2289-93

Showing the most recent 10 out of 28 publications